Skip to content

Serina Therapeutics, Inc.

SER

CIK 0001708599

← back to feed
Revenue (TTM)
$144K
+132.1% YoY Q1 May 2026
Net Income (TTM)
−$22.74M
−72.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.18
−26.5% YoY Q1 May 2026
Gross Margin
35.4%
Q1 May 2026
Operating Margin
-16,060.4%
Q1 May 2026
Net Margin
-15,794.4%
Q1 May 2026
Free Cash Flow (TTM)
−$11.22M
Q1 May 2026
Cash
$24.53M
Q1 May 2026
Total Debt
$11.16M
Q1 May 2026
Shares Outstanding
15M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings